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As the ultimate consumers, patients play an important role in the emergence, spread and
control of bacterial resistance to antibiotics. Improved knowledge of antibiotics and the
problem of resistance, as well as a better understanding of beliefs, pressures/concerns,
and expectations, from both the patient’s and physician’s perspectives, are fundamental
for controlling antibiotic use. There is growing evidence to suggest that empowering
patients through implementation of patient-centered health-care strategies, such as
shared decision-making, in conjunction with educational initiatives help to change
attitudes and behavior, and improve access to and completion of appropriate antimi-
crobial therapy. This, in turn, may help to control the development and spread of
resistance to antibiotics.
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INTRODUCTION
Patients are the end consumers of all medical
treatments, including antibiotics. While this fact
appears obvious, its implications are not always
fully appreciated by authorities responsible for the
design and delivery of health-care services. Bac-
terial resistance to antibiotics is among the most
important health-care problems of our time. This
paper explores the role of the patient in the emer-
gence, spread, and control of bacterial resistance to
antibiotics from both the consumer’s and physi-
cian’s perspectives. It focuses on community-
acquired respiratory tract infections (RTIs), as
these account for the majority of antibiotic pre-
scriptions in the community.
Overcoming Antimicrobial Resistance was the title
of the World Health Organization (WHO) Report
on Infectious Diseases for 2000 [1]. The report
identiﬁed three key issues that have implications
for the patient’s role in bacterial resistance:
 Inadequate access to medical services and anti-
microbial drugs. This remains a key problem in
developing countries, and is also likely to be
important amongst the poorer sections of society
in developed countries, e.g. the 45million people
without health insurance in the USA [2];
 Unnecessary use of antimicrobial drugs for the
wrong infections, or when no infection is pre-
sent;
 Not taking a full course of treatment, sharing
medication with other people, or keeping part of
the course for another occasion. Also, where
antibiotics are available without prescription,
patients may elect to buy the cheapest antibiotic
without regard to its effectiveness.
It is easy to present the role of patients in
negative terms. For example, the WHO report
includes the following paragraph:
‘Patient demand for antimicrobials—some-
times the result of TV, Internet, magazine
or newspaper advertising—also spurs the
development of resistance. In a 1997 study
undertaken in Europe, physicians cited
patient pressure as the number one reason
why they prescribed the wrong antibiotics. In
the United States, 95% of physicians surveyed
had seen an average of seven patients in the
previous six months who had requested spe-
ciﬁc drugs as a result of advertising. Of phy-
sicians questioned, 70% admitted that patient
pressure forced them to prescribe drugs they
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might otherwise have avoided. In a 1995
study undertaken in Peru, two-thirds of those
health workers surveyed claimed that their
primary source of information came from
medical journals. Researchers concluded
otherwise, and wrote that advertising
appeared to be a key information source.
The authors went on to say that this factor
‘‘tended to promote irrational drug use’’.’
Although these statements were somewhat
negative, the WHO report endeavored to move
beyond this to explore the potential beneﬁts of
empowering patients through the implementation
of patient-centered health-care strategies, arguing
that greater patient involvement will improve
access to and completion of appropriate antimi-
crobial treatment. Critical to this discussion is a
clear deﬁnition of the terms ‘patient’ and ‘need’.
By patient we mean people who are accessing
health care. By ‘need’ we mean capacity to beneﬁt
from antimicrobial treatment. Before discussing
the theory and process of patient-centered care
in the treatment of community-acquired RTIs this
paper ﬁrst outlines the knowledge, beliefs and
expectations that both patients and doctors bring
to consultations in this setting.
KNOWLEDGE, BELIEFS , AND
EXPECTATIONS
Patients
Knowledge and beliefs
Beneﬁcial effects of antibiotics. In 1969, the Surgeon
General of the United States stated that ‘We can
close the book on infectious diseases caused by
bacteria.’ Statements like these generated the
impression among the public that antibiotics are
invincible cures. This type of sentiment is still
evident. A survey of 5379 people from nine coun-
tries revealed that 87% thought that antibiotics
speed recovery from respiratory infections and
that 74% perceived them as ‘strong drugs’, 51%
as a ‘savior’, 45% as ‘dependable’ and 16% as
‘gentle’ [3]. Most people perceive antibiotics as
an effective treatment for acute RTIs. However,
misperceptions exist regarding the difference
between bacterial and viral infections and the
appropriate use of antibiotics [4,5].
At the same time, the public are subjected to an
intensely negative view of bacteria through the
advertisement of a range of antibacterial products.
The overall impression is that antibiotics are
keeping an overwhelmingly hostile world of bac-
teria at bay. Search the Internet with the term
‘antibacterial’ and a bewildering number of pro-
ducts impregnated with antimicrobials are found,
from sock, carpet and mattress ‘fresheners’ to
high-chairs and toys. There has been some ﬁght
back against these products. For example the Uni-
ted States Environmental Protection Agency
brought an enforcement action against Hasbro
Inc. for unsubstantiated claims about the public
health beneﬁts of antibacterial toys. Nonetheless,
advertising of these products and of home clean-
ing agents presents the public with a strong nega-
tive message about bacteria or ‘germs’.
Harmful effects of antibiotics. The Internet does
provide some counterbalance to the mainly nega-
tive portrayal of bacteria in the media. Information
about the importance of the normal human bacter-
ial ﬂora is readily available on the world-wide
web. Search for ‘normal bacterial ﬂora’ and there
are a growing number of informative websites
with a more balanced view of the complex rela-
tionship between humans and bacteria (e.g. http://
gsbs.utmb.edu/microbook/ch006.htm). The fol-
lowing extract is published at the Earthlife website
(http://www.earthlife.net/prokaryotes/human.
html):
‘Many people may think of bacteria only as
the causative agents of disease, however,
the disease causing species only represent a
very small percentage of the total number of
species of bacteria. It will come as a surprise
then to realize that we as human beings live in
harmonywithmillions of bacteria all the time.
Most of these bacteria live within us, harm-
lessly going about their short lives without
causing us any problems at all. Some in fact
may even be beneﬁcial. A small percentage
live on us rather than in us, these are rela-
tively few in numbers of individuals and
number of species compared with our inter-
nal ﬂora but they and their progeny will be
there all our lives.’
Even this extract provides only a single, tenta-
tive statement that the normal human ﬂora ‘may
even be beneﬁcial’. In fact the reality is that the
normal ﬂora fulﬁls key roles both in digestion and
as a key component of our host defenses [6].
Nonetheless, the message does not seem to have
got through to the public, perhaps in part due to
the messages implicit in information sheets about
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antibiotics. These suggest that it is only ‘unneces-
sary’ antibiotics that are harmful and tend to
portray a very negative relationship between bac-
teria and human health. In reality, antibiotics
always damage the normal human bacterial ﬂora:
the key question is when do the beneﬁts of treat-
ment outweigh the inevitable risks? Prescribing is
more likely to be inﬂuenced when risks to indivi-
duals from antibiotics (rather than trial evidence
for marginal beneﬁt) are emphasized [7].
Antibiotic resistance. Misperceptions also exist
regarding bacterial resistance to antibiotics.
Patients will commonly say that taking antibiotics
may cause they themselves to become resistant to
antibiotics. They rarely say that antibiotics cause
their bacteria to become resistant. The aforemen-
tioned multinational survey of 5379 people found
that 59% believed that antibiotics could undermine
their natural immunity [3]. When asked about
negative features only a minority named any.
None of the respondents mentioned antibiotic
resistance as a negative consequence of taking
antibiotics.
Expectations
Patients’ expectations regarding antibiotic pre-
scribing and consultations for acute respiratory
symptoms in primary care have mainly been stu-
died in North America and Western Europe
(Table 1).
Symptoms that require antibiotic treatment. Patients
present with symptoms (runny nose, tiredness,
cough) rather than diagnoses (sinusitis, inﬂuenza,
bronchitis). They want rapid relief from their
symptoms and are less concerned with bacterial
eradication. Only a minority (37%) of 5379 people
believed that antibiotics should be taken for the
‘common cold’ whereas a majority believed they
should take antibiotics for sore throat (72%), fever
(67%), earache (65%), thick catarrh (64%), bad
cough (65%), and ﬂu (64%) [3]. Surveys of patients
visiting their doctor with acute respiratory symp-
toms show that most are expecting to receive
antibiotics [10,11,14,16,18,19]. Belief that their
symptoms are caused by bacterial infection is a
powerful stimulus to seek antibiotic treatment
[3,19]. However, 40% of students with upper
respiratory symptoms expected to receive antibio-
tics even if they believed that they had a viral
infection [19]. Furthermore, there is some evidence
that patients know the kinds of symptoms that are
likely to induce doctors to prescribe and will
report symptoms such as sinus pain or productive
cough with green sputum even when they do not
have them [3,15].
Previous experience of antibiotics. Previous use of
antibiotics prompts patients to expect antibiotics
when the same symptoms occur again [4,7,15].
Conversely, strategies that persuade patients that
they do not need antibiotics for an episode also
give them conﬁdence that they do not need to con-
sult their doctor when they have similar symptoms
in the future [23,24]. Patients who have lived in
countries where antibiotics are available without
prescription are more likely to demand antibiotics
and to obtain antibiotics without prescription,
even when they have moved to countries where
this is theoretically impossible. For example, 26%
of subjects surveyed in the USA said that they had
obtained antibiotics without prescription, either
from pharmacies or from a supplier outside the
USA [18]. Information from other countries where
antibiotics are only available on prescription also
suggests that people regularly obtain antibiotics
without prescription [3].
Return to normal activity (work/school/day-care). The
symptoms of ‘minor’ respiratory infections can
seriously disrupt patients’ lives. In a study of 79
patients with acute bronchitis, it took 3–4weeks
beforemost patients were well and able to perform
all their usual daily activities again [25]. Similarly,
the majority of ambulatory patients with commu-
nity-acquired pneumonia were not fully recovered
30days after the onset of symptoms [26]. Provid-
ing patients with information about the likely time
course of their symptoms signiﬁcantly reduces the
chance of repeat consultation, regardless of
whether or not they received antibiotics at the
initial consultation [27].
Erosion of conﬁdence in doctors. On both sides of the
Atlantic, recent high-proﬁle cases in which doctors
were shown to be negligent or worse are bound
to erode the public’s trust in doctors [28,29]. A
doctor’s reluctance to prescribe antibiotics may be
perceived by the patient as an attempt to save
money from the over stretched health-care budget.
Doctors are concerned that not prescribing anti-
biotics will disturb their future relationship with
patients and families in their practice [30].
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Table 1 Studies of patient expectations for antibiotic prescribing and consultations for acute respiratory symptoms in
primary care
Country Subjects Reported influence of expectations
USA [8] 1368 children attending 44 practices in
the Ambulatory Sentinel Practice Network
Parental expectation that an antibiotic would be given was
associated with a twofold increase in the likelihood of a
diagnosis of bronchitis and a halving in the likelihood of a
diagnosis of an upper respiratory tract infection (RTI)
USA [9] 266 patients attending two outpatient
clinics
Patients at the intervention clinic received a patient-based
educational intervention. Antibiotics were prescribed to
64% and 85% of patients at the intervention and control
clinics, respectively (P< 0.001). Patient satisfaction with the
visit did not differ between intervention and control clinics
(69% of intervention and 63% of control clinic patients
reported very good or excellent satisfaction; P> 0.2). After
adjustment for age, sex, duration of illness before the visit,
reason forvisit, andclinician specialty, therewasnodifference
between intervention and control clinics in the proportion of
patients reporting very good or excellent satisfaction (ad-
justed relative risk for high satisfaction at the intervention
clinic, 1.1[95% Confidence Interval [CI], 0.81–1.3])
USA [10] 113 patients with symptoms of acute RTI Sixty-five per cent of patients expected to receive antibiotics.
Physicians had some ability to perceive this expectation and
frequently prescribed antibiotics for patients who expected
them. Antibiotics were prescribed to >75% of patients with
sinusitis orbronchitis andto18%of thosediagnosedwithviral
infections.No associationwas foundbetween prescription for
antibiotics and patient satisfaction. However, patient satisfac-
tion correlated with the patients’ report that they understood
the illness and that thephysicianspentenough timewith them
Germany [11] Ten general practitioners and 185 randomly
identified patients
Nearly half of the patients expected a drug prescription from
their doctor; 68% received one. Doctors recognized the
expectation of a prescription in only 40.7% of patients; 82.6%
of patients expecting a drug were issued a prescription.
Nearly all patients (45/48) who expected a drug according to
their doctor’s judgement left the surgery with a prescription,
and 58.4% of the remaining patients were prescribed a drug.
There was no difference in satisfaction scores between
patients whose expectations were or were not fulfilled
USA [12] 237 patients with acute respiratory
symptoms attending one practice
Patients’ most important goal was to obtain a diagnosis
(57%). They usually got more reassurance, medication, and
personal interest than they had expected (P¼ 0.0001). In a
multivariate model, patients’ satisfaction was related to the
degree of personal interest and reassurance they had
received and whether they felt they had received the right
medication (r2¼ 0.45, P¼ 0.0001)
USA [13] 104 patients (>14 years) with upper RTI
from three practices
Stress scores were calculated for each patient’s family using
several standard instruments.Measures of stress and support
were related to the use ofmedical services, seeking additional
medical care, extraphone calls, and longer perceivedduration
of illness. Physicians prescribed more medications, ordered
more laboratory tests, and scheduled more return visits for
patients with high stress or low support scores
USA [14] 210 patients (aged >18 years) with upper
RTI symptoms attending a walk-in clinic
The 210 patientswere categorized into two groups: thosewho
believed that antibiotics were necessary (157[75%]) and those
who believed antibiotics were unnecessary (53[25%]). The
only statistically significantdifferencebetween the twogroups
was in patients with sinus pain: 109 (69%) wanted anti-
biotics comparedwith 23 (43%)whodidnot (P< 0.001).Of the
210 patients, 130 completed postvisit questionnaires, 129
(99%) of whom reported satisfaction with the clinic visit. All
patients who either desired or received antibiotics indicated
they would likely seek medical care for future upper RTIs
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Table 1 continued
USA [15] 298 outpatient visits for acute RTIs in
18 family practices
Patients were observed to pressure physicians for medication.
The types of patterns identified were direct request, candidate
diagnosis (a diagnosis suggested by the patient), implied
candidate diagnosis (a set of symptoms specifically indexing a
particular diagnosis), portraying severity of illness, appealing
to life circumstances, and previous use of antibiotics. Also,
clinicians were observed to rationalize their antibiotic pre-
scriptions by reporting medically acceptable reasons and
diagnoses to patients
USA [16] 10 physicians and 295 parents from
two private pediatric practices
Fifty per cent of parents expressed a previsit expectation for
antibiotics. Among these parents, only 1% made a direct verbal
request for them. Even when no direct requests for antibiotics
were made, physicians still perceived an expectation for
antibiotics 34% of the time. Among parents who did not receive
expected antibiotics, those offered a contingency plan from the
physician (i.e. the possibility of receiving antibiotics in the future
if their child did not get better) had a significantly higher mean
satisfaction score than parents not receiving a contingency plan
(76 vs. 58.9; P< 0.05)
USA [17] 10 physicians and 306 parents of children
with acute respiratory symptoms from
two private pediatric practices
Based on multivariate analysis, physicians’ perceptions of
parental expectations for antibiotics was the only significant
predictorofprescribing forconditionsofpresumedviral etiology.
When physicians thought a parent wanted an antibiotic, they
prescribed them62% of the time vs. 7%of the timewhen they did
not think the parent wanted them. However, physician prescrib-
ingbehaviorwasnot associatedwith actualparental expectations
for receiving antibiotics. In addition, when physicians thought
theparentwanted adrug, theywere also significantlymore likely
to give a bacterial diagnosis (70% of the time vs. 31% of the time).
Failure to meet parental expectations regarding communication
events during the visit was the only significant predictor of
parental satisfaction.
Failure to provide expected antibiotics did not affect
satisfaction
USA [18] 192 adults from an urban community A majority of subjects reported a belief in the effectiveness of
antibiotics for upper RTIs and indicated they are likely to seek
care for these conditions. Many (26%) had obtained antibiotics
from sources other than a physician’s prescription (e.g. directly
from pharmacists or a supplier outside the United States).
Subjects with a cultural background from countries where
antibiotics are available over the counter were more likely to
use antibiotics not prescribed by a physician than those from
countries with variably enforced regulations or the United States
(40%, 30%, and 20%, respectively; P¼ 0.049)
USA [19] 129 students with upper RTI symptoms Fifty-five per cent of students expected an antibiotic prescription.
Antibiotic expectation was significantly more likely among
students who thought they had a bacterial vs. a viral infection
(90% vs. 40%; P< 0.01). A clear diagnosis, an explanation of the
rationale for treatment, and an antibiotic prescription were
significantly associated with patient satisfaction. Clinicians
prescribed an antibiotic for 36% of the students; only 13% of
these 46 students had requested an antibiotic during the visit
Belgium,
Columbia,
France, Italy
Morocco,
Spain,
Thailand,
Turkey,
UK [3]
Telephone interviews of 5379 subjects
randomly selected (approximately 600
per country)
Themajority of thosequestionedbelieved (butdidnotnecessarily
expect) that for most RTIs, antibiotics should be prescribed: sore
throat, 72%; fever, 67%; earache, 65%; thick catarrh, 64%; bad
cough, 65%; and flu, 64%; but common cold, only 37%. Of those
questioned 11%admitted that they had , to exaggerate symptoms
to get antibiotics from their physician. Twenty-four per cent of
respondents said that they routinely saved part of the course for
future use, but the percentage variedwidely by country (from 4%
of the 600 interviewees in the UK to 41% in Italy).
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Doctors and other health-care professionals
Knowledge and beliefs
Studies into the knowledge and beliefs held by
health-care professionals regarding antibiotics are
summarized in Table 2.
Beneﬁcial effects of antibiotics. Infectious diseases
still kill more people than either cardiovascular
diseases or cancer, but over the past century,
doctors in developed countries have seen a
marked reduction in mortality from these diseases
[36–38]. Most doctors probably overestimate the
contribution of antibiotics to this decline [39–41].
In Sweden, linear regression analysis showed that
mortality rates declined faster in septicemia,
syphilis and nonmeningococcal meningitis after
the introduction of antibiotics. In contrast, for
the 10 other infectious diseases studied (scarlet
fever, erysipelas, acute rheumatic fever, puerperal
sepsis, meningococcal infection, bronchitis, pneu-
monia, tuberculosis, typhoid fever, and acute
gastroenteritis) no such accelerated decline in
mortality could be detected [39]. A similar analysis
in The Netherlands focused on evidence for a
longer lasting acceleration of the mortality decline
after the introduction of antibiotics. Estimated
differences in per cent per annum mortality
change were 10% or larger for puerperal fever,
scarlet fever, rheumatic fever, erysipelas, otitis
Table 1 continued
UK [20] 716 patients with sore throat Most people (69%) had their concerns very well dealt with;
this was a better predictor of whether patients were very
satisfied (odds ratio 88.6; CI 38.4–177.4) than whether an
antibiotic was prescribed (odds ratio 2.97; CI 1.54–5.74).
Satisfaction was not predicted by any other variable
UK [21] 787 patients with lower RTIs and 76
general practitioners
Eighty-four per cent of patients thought that their symptoms
were caused by an infection, 83% thought that antibiotics
would help and 71% expected a prescription. Doctors
thought that 20% of antibiotic prescriptions were definitely
indicated and 20% were definitely not indicated.
Doctors considered antibiotics definitely indicated in only 1%
of the group in whom patient pressure influenced the
prescribing decision. Patients who did not receive an
antibiotic that they wanted were much more likely to express
dissatisfaction. Dissatisfied patients reconsulted for the same
symptoms twice as often as satisfied patients
Canada [22] 20 family physicians seeing patients
with acute infections over a 2-day period
Perceived patient demand was reported in 124 (48%) of 260
physician–patient encounters; however, in almost 80% of
these encounters, physicians did not think that the demand
had much influence on their decision to prescribe an
antibiotic. When clinical need was uncertain, 28 (82%) of 34
patients seeking an antibiotic were prescribed one, and
physicians reported that they were influenced either ‘mod-
erately’ or ‘‘quite a bit’’ by perceived patient demand in over
50% of these cases
USA [4] 961 adults from the community of
Kentucky and Louisiana
Seventy-two per cent of patients would seek care for a
condition of 5 days’ duration with cough, sore throat, and
discolored nasal discharge.
Sixty-one per cent believed that antibiotics are effective for a
condition of 5 days’ duration with cough, sore throat, and
clear nasal discharge; 79% said that they believed antibiotics
are effective when there is discolored nasal discharge
(P¼ 00001). The strongest predictor of both likelihood of
utilization and belief in effectiveness of antibiotics was usual
use of antibiotics for the upper RTI symptom complexes. The
authors concluded that patients lack understanding of the
normal presentation of an upper RTI and the effectiveness of
antibiotics as a treatment
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media, tuberculosis, and bacillary dysentery [40].
Both studies suggest that antibiotics made a small
but important contribution to the decline in mor-
tality from acute infections in the 20th century.
Nonetheless, health-care professionals and the
public need to be reminded that improvements
in public health were responsible for most of this
achievement.
Doctors should also be aware that antibiotics
only have a modest impact on the symptoms of
acute bacterial RTIs [42–52]. Any discussion about
prescribing antibiotics in general practice needs to
start from an honest appraisal of the modest ben-
eﬁts that they achieve for these infections [7]. Too
much emphasis on the distinction between viral
and bacterial infections can create an artiﬁcial
dichotomy, where antibiotics provide no beneﬁt
against viral infections but are seen as essential to
recovery from bacterial infections [7].
Harmful effects of antibiotics. As with patients,
many doctors may have little appreciation of the
importance of the normal bacterial ﬂora to human
health and of the damaging effect of antibiotics on
this ﬂora. The normal ﬂora of the throat [53,54], gut
[55,56], and vagina [57,58] form an important bar-
rier to colonization by pathogenic bacteria or fungi
that is disturbed by prior administration of anti-
biotics. This protective effect results both from the
formation of a physical barrier and from
metabolic effects [56]. The metabolic effects of
the normal gut ﬂora also have important implica-
tions for the risk of breast and colon cancer [59–61]
and there is epidemiological evidence linking anti-
biotic use in women with an increased risk of
breast cancer [62]. Antibiotic treatment undoubt-
edly increases the risk of colitis caused by Clos-
tridium difﬁcile [63,64] and of vaginal candidiasis
[65].
Antibiotic resistance and antibiotic prescribing. While
most doctors acknowledge that antibiotic use
relates to antibiotic resistance, they are loath to
admit that their own prescribing contributes to the
problem. Rather, they are liable to pin the blame on
Table 2 Surveys of professionals about antibiotic prescribing for acute respiratory symptoms in primary care
Country Subjects
Prescribed
antibiotics
Factors influencing antibiotic
prescription
USA [31] 265 members of
the American Board
of Family Practice
63% for bronchitis Smoking (90% use antibiotics as first-choice
treatment in smokers).
Physicians’ age, sex, years in practice, and
location did not influence their decisions
USA [32] 444 members of the
American College
of Clinical Pharmacy
Antibiotics were recommended for upper
respiratory tract infections (RTIs) or bronchitis
more often if patients’ symptoms included
discolored nasal discharge or sputum.
Board-certified pharmacists were less likely to
recommend antibiotics
Canada [33] 136 primary-care family
physicians and
pediatricians
24% to children
with cough
The proportion of doctors who would
prescribe antibiotics increased to 45% when
symptoms had worsened in the 24 h before the
office visit
Australia [34] 20 general practitioners Cough productive of yellow sputum; presence
of sore throat; fever; and colored nasal mucus
increased the probability of an antibiotic being
prescribed.
USA [35] 366 pediatricians
and family physicians
86% for bronchitis;
42% for the
common cold
Ninety-seven per cent of physicians agreed
that overuse of antibiotics is a major factor
contributing to the development of antibiotic
resistance, and 83% agreed that they should
consider selective pressure for resistance in
their decisions on providing antibiotic
treatment for upper RTIs in children in their
practices. However, many reported practices
do not conform to the recently published
principles for judicious antibiotic use
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other doctors (primary-care doctors blame their
hospital colleagues and vice versa). If doctors from
primary and secondary care are cornered, they
will probably unite temporarily in order to blame
veterinary surgeons.
Twenty-ﬁve per cent of 392 family physicians
surveyed in British Columbia, Canada, did not
believe that prior antibiotic use increased personal
risk for acquiring drug-resistant infection. More-
over, 23% did not believe that antibiotic use was an
important factor in promoting resistance in their
communities [66]. In reality, there is good evidence
linking prior exposure to antibiotics to signiﬁ-
cantly increased risk of infection with drug-resis-
tant bacteria, both in the community [67] and in
hospital [68]. This relationship is clearly seen in
studies that collect data on exposure to antibiotics
and isolation of resistant bacteria from individual
patients [67,68]. However, ecological studies with
data from populations of patients are likely to
obscure the relationship between antibiotic expo-
sure and resistance [68].
Expectations
Howie [30] identiﬁed four nonbacteriological
determinants of antibiotic prescribing for respira-
tory symptoms:
 The doctor’s anxiety about his or her workload;
 The response of doctors to social pressures;
 Misinterpretation of underlying reasons for a
consultation;
 Fear of the possible development of sequelae to
streptococcal illness.
Subsequent studies of the factors that inﬂuence
antibiotic prescribing support the importance of
these four determinants. For example, in one
study doctors explained their prescription of anti-
biotics to patients whom they did not think had
a genuine clinical need on the basis of the pres-
sure from patients to do so, combined with social
factors and the doctor’s own workload [69]. Sev-
eral of the studies in Table 1 show that doctors
commonly misinterpret the reasons for a patient’s
consultation and their expectations for antibiotic
treatment.
Even when doctors acknowledge the relation-
ship between prescribing and resistance, and the
need for prudent prescribing against RTIs, their
reported prescribing practices do not conform to
recently published principles for prudent anti-
biotic use [35]. One reason for this may be that
doctors ﬁnd it difﬁcult to differentiate between
RTIs, in particular bronchitis and pneumonia.
In a qualitative study of coughing involving 24
community physicians in the UK, clinical signs
and symptoms often left the physicians with rea-
sonable diagnostic doubt. Their prescribing beha-
vior was also determined by both doctor- and
patient-related factors (e.g. having missed pneu-
monia once, patient expectations). The ‘chagrin
factor’ explains why these factors lead to a shift
in the action threshold, in favor of antibiotics
[70].
Increasing patient demand. It should not be assumed
that doctors inevitably give way to pressure from
patients to prescribe and it is important tomeasure
doctors’ perceptions about pressure separately
[71]. While it may be true that doctors are more
likely to feel pressurized if the patient expects a
prescription, 52% (220/420) of doctors in one
study did not feel under pressure when the patient
hoped to receive a prescription [72].
Pressure to see more patients.Doctors in primary and
secondary care are under pressure to see more
patients and most believe that it takes longer to
reassure a patient that they do not need an anti-
biotic than simply to prescribe one [7]. Interviews
with 21 primary-care doctors in the UK revealed
that they believed that if a prescription was issued
then the consultation was short and the patient
seemed satisﬁed. A typical doctor’s opinion was,
‘You can’t just say, ‘‘It’s viral, you don’t need
antibiotics, go away,’’ because they feel they’re
being fobbed off. They feel that their illness is
not being taken seriously’ [7]. Conversely,
attempting to change patients’ beliefs and expec-
tations in the consultation was often perceived as
time consuming and unrewarding. One practi-
tioner said, ‘You spend 15min trying to educate
them, when they will go out disillusioned, come
back the next day and see someone else, mak-
ing you feel 5min would be better spent just
giving them a prescription and getting rid of them’
[7].
Conﬂicts of interest between the patient, the provider
organization, and public health.Under managed care
in its various forms, restrictions on clinicians have
now become commonplace. Modern information
systems make it possible for managers to monitor
and control practitioners’ behavior by such mea-
sures as utilization review, incentives and
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disincentives, and pre-authorization for proce-
dures and referrals. This is often so destructive
of professional morale that it may become self-
defeating. Self-imposed limits are more tolerable
than those imposed from above, but if doctors
stand to gain from the decisions themselves, their
interests are potentially in conﬂict with those of
their patients [73]. Managed care is a relatively
recent development that focuses on the tensions
between the cost and quality of care [74]. However,
doctors have always had to balance their conﬂict-
ing duties: ‘ﬁdelity’ to the interests of an indivi-
dual patient and ‘stewardship’ for the health-care
resources that are entrusted to them by society [75].
The ‘principal-agent’ relationship was devel-
oped inmainstream economics tomodel situations
in which the consumer is ill-informed, but can use
an agent to make decisions on his or her behalf
[76]. In applying this concept to health, most of the
literature has focused on the doctor–patient rela-
tionship, in which the doctor makes decisions on
behalf of the patient purely in relation to the
patient’s interests. However, there has been some
extension of the notion of agency to the relation-
ship between citizens and those making health-
care decisions on their behalf. A form of societal
agency relationship is envisaged where the prin-
cipals are citizens and the aim is tomaximize social
welfare rather than patient utility [76]. It is deba-
table whether a doctor can act as a perfect agent
both for an individual patient and for the citizens
that he or she serves. Conﬂict between the (impli-
cit) role of societal agent and the (explicit) role of
patient advocate is intrinsic to the doctor’s role
[77–82], and can be expected to increase as the oft-
quoted ‘gap’ between demand and supplywidens.
If doctors are to act as both the patient’s and the
citizen’s agent they may be left with moral and
ethical problems preventing them from making
disinterested rationing decisions [76].
The problem of antibiotic resistance provides an
important focus for debate on these key issues
because the conﬂict of interests between indivi-
dual patients and society is not due to constraints
on health-care budgets.
Attitudes to practice guidelines. There is increasing
concern about the quality, reliability and indepen-
dence of practice guidelines. A review of 431
guidelines published between 1988 and 1998
found that 67% did not report any description
of the type of organizations involved in the
development process, 88% gave no information
on searches for published studies, and 82% did not
give any explicit grading of the strength of recom-
mendations. There was improvement over time at
including search details (from 2% to 18%;
P< 0.001) and explicit grading of evidence (from
6% to 27%; P< 0.001). The authors concluded that,
despite improvement over time, the quality of
practice guidelines developed by specialty socie-
ties is unsatisfactory [83]. The AGREE (Appraisal
of Guidelines for REsearch & Evaluation) project
is a response to this problem. Funded by the
European Union, AGREE is developing guidance
on good practice for guideline developers (http://
www.agreecollaboration.org).
While guideline developers may have reached a
consensus about good practice, their standards do
not reﬂect the current beliefs of practitioners. A
survey of 1199 doctors in Italy revealed that prac-
tice guidelines were generally perceived to be less
useful than other sources of medical information
(e.g. personal experience, conferences, colleagues,
articles, the Internet, and textbooks) [84]. Most
physicians thought that guidelines were devel-
oped for cost-containment reasons and expressed
concerns about their limited applicability to indi-
vidual patients and local settings. Furthermore,
most respondents did not favor the involvement
of health professionals other than physicians in
guideline development. Thus, having a multidis-
ciplinary guideline group, which is regarded as a
key element of good practice, may actually make a
guideline less credible to practicing doctors.
Efﬁcacy and availability of alternatives to antimicrobial
treatment.Anti-inﬂammatory drugs are underused
in acute RTIs [85]. For example, despite evidence
of their effectiveness, two studies have shown that
bronchodilators are only prescribed for 6–17% of
patients with bronchitis [31, 86]. Patient informa-
tion about the likely course of symptoms for acute
RTIs, combined with advice about symptomatic
relief, is a powerful alternative to antibiotic pre-
scribing [87].
Fear of litigation for malpractice. Many doctors dis-
trust guidelines because they do not believe that
they are sufﬁciently sensitive to important differ-
ences between individual patients [84,88]. Doctors
who are high prescribers of antibiotics show other
evidence of a defensive attitude in their practice
[89].
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Doctors are unsure whether following a guide-
line will be sufﬁcient defense against a charge of
negligence if they do not prescribe antibiotics to a
patient who subsequently is shown to have a
serious bacterial infection [84]. Unfortunately
there is some basis for this fear. A court can declare
a policy or guideline as insufﬁcient or unaccepta-
ble; the court is sovereign and can decide upon the
standard according to its own legal policies, which
are usually aimed at improving public health.
Thus, if the court ﬁnds a certain policy—even
one approved by ofﬁcial bodies—to be insufﬁcient,
it can declare it as nonstandard and set its own
standard. The following quote is from the book
International Medical Malpractice Law, ‘A common
practice (regardless if founded on guidelines) sim-
ply may not be good enough to fulﬁll the standard
required by the law’ [90]. In 1993 the Supreme
Court of Canada expressed the view that ‘confor-
mity with standard practice (based on policy or
guidelines) in a profession does not necessarily
insulate a doctor from negligence where the stan-
dard of practice itself is negligent’ [91]. In the UK,
the House of Lords has stated the view that the
court can, in rare cases, reach a conclusion that a
professional standard is not based on a rational
analysis, and that the experts express views
that are not logical or responsible [92]. However,
such situations are rare and the court will usually
accept an antibiotic policy as a standard and act
accordingly.
Influences on antibiotic prescribing
Various factors are reported to inﬂuence the pre-
scribing of antibiotics by doctors (Tables 2 and 3).
The most consistently reported inﬂuence is the
nature of the patient’s symptoms. Reporting of
discolored secretions (nasal discharge or sputum)
and sinus tenderness are strongly associated with
prescribing [32,34,69,89,94,95,98,101]. There is also
evidence that doctors rationalize their prescribing
by reporting medically acceptable diagnoses, such
as bronchitis or sinusitis [8,15,35,100]. A doctor’s
perception of either high stress or low social sup-
port is associated with increased antibiotic pre-
scribing [13]. This is consistent with the results of
studies that have examined the inﬂuence of non-
bacteriological factors on prescribing [30,69]. If
doctors perceive that patients are expecting anti-
biotics, they are more likely to provide diagnoses
such as bronchitis [8,15] and more likely to pre-
scribe antibiotics [11,17].
High prescribers of antibiotics tend to be high
prescribers of other drugs [104,105]. There is no
consistent evidence about characteristics such
as age of the prescriber or time since qualiﬁcation
as predictors of prescribing; few of the studies
that examine these variables use multivariate ana-
lysis to adjust for other associated variables. When
this is done, the age of the prescriber does not
appear to be an important predictor of prescribing
[100,105]. In comparison with other practices,
those that train junior doctors in primary care have
been shown to prescribe fewer antibiotics as well
as a higher proportion of formulary drugs [105].
Of course, budgetary limitations also are an
increasingly important inﬂuence on antibiotic
prescribing.
Patient–doctor interaction: bridging the gap
Patient–doctor communication is a dual process
whereby two players with different objectives and
backgrounds try to ﬁnd a joint solution to a pro-
blem. Patients should play an active part in reach-
ing this solution in order to maximize the
acceptability and effectiveness of treatment. Sev-
eral studies include information about the inter-
action between patients and doctors (Tables 1,2,3).
Despite their different designs and settings, sev-
eral common ﬁndings emerge:
 Satisfaction is increased by providing informa-
tion (including a diagnosis), enough time and
reassurance, combined with an interest in the
patient’s problems [10,12,16,17,19]. In one study,
failure to meet parental expectations regarding
communication events during the visit was the
only signiﬁcant predictor of parental satisfaction
[17]. Failure to provide expected antimicrobials
did not affect satisfaction in this study nor in two
additional studies [9,10].
 Doctors are not good at recognizing patient
expectations. In formal studies, they correctly
identify <50% of patients who are expecting
antibiotic treatment [10,11,17,20].
 Some patients seem to be all too aware of what
inﬂuences doctors to prescribe antibiotics. They
exert pressure on the doctor to prescribe, using
tactics such as suggesting candidate diagnoses
that are more likely to elicit a prescription or
exaggerating the severity of their symptoms or
their lack of social support [3,15].
The results of these studies are consistent
with those of more general studies of patient
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Table 3 Studies of influences on antibiotic prescribing for acute respiratory symptoms in primary care
Country Subjects Prescribed antibiotics Factors influencing the consultation
USA [93] 1525 adult patients with
acute bronchitis
85% of patients with bronchitis Purulent nasal discharge; sinus tenderness moderately associated with
antibiotic prescribing. Patient age, gender, duration of illness or days
off work did not influence prescribing
USA [94] Adult patients with upper
respiratory illness
33% of all upper respiratory
tract infections (RTIs)
Purulent nasal discharge, green phlegm, and tonsillar exudates were
each independently associated with antibiotic prescribing
Japan [95] 302 patients with bronchitis
and 1165 with upper RTIs
68% of patients with bronchitis Purulent sputum, pharyngeal exudates, chest signs, and pyrexia were
significantly associated with antibiotic prescribing
USA [96] National Ambulatory Care
Surveys 1980–94
66% of patients with bronchitis In every year of the study, white, non-Hispanic patients aged
<65-year-old were more likely to receive antibiotics than
nonwhite patients or patients aged 65 or older. There was a significant
increase in prescribing from 59% of patients in1980 to 70% in 1994
New Zealand [97] Computerized records of
100 222 consultations from
17 practices
78% of all upper RTIs There was no statistically significant difference in the likelihood of a
successful outcome with or without antibiotic therapy (w2¼ 0.76;
P> 0.05)
USA [98] 482 patients (>4 years) In an adjusted model, the variables significantly associated with
antibiotic prescribing were physical findings of sinus tenderness,
rales/rhonchi, discolored nasal discharge, and postnasal drainage. The
presence of clear nasal discharge on examination was negatively
associated with prescribing
Canada [99] 4344 children (<16 years)
attending offices or urgent care
centers
76% of children with pharyngitis
and 90% of children with bronchitis
Urgent care physicians were significantly more likely than pediatri-
cians or family physicians to prescribe immediate antibiotics and to
disregard guidelines
USA [35] 7531 encounters with
children aged 1–6 years
43% of all encounters;
72% of upper RTI office visits;
11% of checkups;
18% of telephone calls
Therewaswidevariability in the overall antibiotic-use rates among the 25
physicians (1–10 courses per child per year). There was an even wider
variability in some diagnosis-specific rates; bronchitis and sinusitis in
particular. Those with the highest antibiotic prescribing rates had up to
30% more return office visits. Physicians who prescribed antibiotics for
purulent rhinitis were more likely to see parents who believed that their
children should be evaluated for cold symptoms
USA [89] 722 patients with a runny
nose, blocked nose, or cough
The best independent predictor of an antibiotic prescription was the
individual antibiotic prescribing rate, which expresses the personal
habit of the general practitioner in prescribing antibiotics (adjusted
odds ratio [OR] 5.27, 95% confidence interval [CI] 3.22–8.62). Others
were the diagnostic labels: ‘sinusitis’ (adjusted OR 2.80, 95% CI 1.2–
6.49) and ‘flu–like syndrome’ (adjusted OR 0.08, 95% CI 0.01–0.45), and
the sign ‘sinus tenderness’ (adjusted OR 4.37, CI 2.15–8.89). The
antibiotic prescribing behavior intensified with an increased tendency
to prescribe medication in general (beta ¼ 0.46; P< 0.001) and with an
increased defensive attitude (beta ¼ 0.22; P< 0.05)
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Table 3 continued
Country Subjects Prescribed antibiotics Factors influencing the consultation
USA [15] 298 outpatient visits
for upper RTIs in 18
practices
68% of all visits 79% of antibiotic prescriptions were determined to be unnecessary according to
the Centers for Disease Control and Prevention guidelines. Patients were
observed to pressure physicians for a prescription
USA [100] Patients with acute
infections attending
73 practices
Low prescribers;
high prescribers
Low prescribers and high prescribers were of similar ages and saw similar
numbers of patients of similar ages with very similar presenting complaints. Both
groups diagnosed urinary tract and skin and soft-tissue infections at similar rates,
but differed markedly in their rates of diagnoses of RTIs. High prescribers
diagnosed bacterial RTIs in 65.4% (147/225) of their patients; low prescribers
diagnosed bacterial RTIs in 31.0% (66/213 (P< 0.001)
The Netherlands [101] Nationwide survey
of 335 000 patients
attending 161 family
physicians
33% of first contacts for
otitis media, upper RTI,
sinusitis, and tonsillitis
An antibiotic was prescribed most frequently for sinusitis (72%) and acute
tonsillitis (74%), but much less frequently for otitis media and acute upper
RTI
UK [102] 518 patients with
acute lower RTIs
76% Thirty per cent of patients reconsulted for similar symptoms within the next
28 days (29% of those who were given antibiotics and 33% of those who were
not). Forty-one per cent of patients who had seen their general practitioner 15 or
more times in the previous 2 years reconsulted, compared with 13% of those who
had made fewer than 5 visits
UK [69] 1089 adults with lower
RTIs visiting 115
general practitioners
75% The doctors stated that only 33% of prescriptions were definitely indicated and
that 20% were definitely not needed. Logistic multivariate analysis revealed that
all of the following were independent predictors of antibiotic prescribing: age of
general practitioners and patients, discolored sputum, fever, signs on chest
examination, and ‘other factors’. These ‘other factors’ included patient pressure,
social factors, physician work pressure, and prior experience with the patient.
They were particularly likely to be associated with prescribing to patients whom
the doctors thought did not need antibiotics
USA [103] 531 pediatric office visits
to physicians participating
in the National Ambulatory
Medical Care Survey
75% of children with
bronchitis
Antibiotics were prescribed to 44% of patients with common colds, 46% with
upper RTIs, and 75% with bronchitis. After controlling for confounding factors,
antibiotics were prescribed more often for children aged 5–11 years than for
younger children (OR, 1.94; 95% CI, 1.13–3.33) and rates were lower for
pediatricians than for nonpediatricians (OR, 0.57; 95% CI, 0.35–0.92)
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interactions with doctors in prescribing decisions.
They also reveal misunderstandings relating to
patient information unknown to the doctor; doctor
information unknown to the patient; conﬂicting
information; disagreement about attribution of
side-effects; failure of communication about the
doctor’s decisions; and relationship factors. All
these misunderstandings were associated with
lack of patient participation in the consultation
in terms of the voicing of expectations and pre-
ferences or the voicing of responses to doctors’
decisions and actions [106].
Doctors feel more conﬁdent about making pre-
scribing decisions when they know the patient
[69,107]. However, the doctor is unlikely to know
patients who present with acute RTIs. Patients will
either make an urgent appointment during ofﬁce
hours or seek help out of hours. In most health-
care systems it is increasingly unlikely that they
will see their regular doctor. Moreover a high
proportion of patients with infections are other-
wise healthy so that even their family doctor may
not know them well.
PATIENT-CENTERED CARE
What is patient-centered care?
There is a great deal of confusion among health-
care professionals about what exactly it means to
practice patient-centered medicine. This confusion
is unsurprising in view of the many terms used to
describe related concepts such as patient-centered
care, shared decision-making, patient empower-
ment, informed patient choice, and concordance.
In order to develop effective patient-centered
interventions for reducing unnecessary antibiotic
prescribing, it is important to understand the
similarities and differences between such con-
cepts. Here we will describe the main approaches
in order to identify what we believe to be the key
issues.
Patient-centered care
Patient-centered care is best described as a general
philosophy whereby the patient is valued as a
person and is seen as a partner in the process of
medical care, rather than as an inferior and passive
recipient of professional expertise. It also recog-
nizes that there is more to illness than physical
symptoms and capitalizes on the therapeutic nat-
ure of the consultation itself. Patient-centered care
has been deﬁned and measured as a professional
attitude (e.g. valuing the patient), as a knowledge
set (e.g. about what is important to patients), and
as a set of skills (e.g. sharing with the patient in
decision-making and being responsive to the
patient’s feelings). In fact, it is a broad construct
encompassing all these factors [108]. While there is
a general consensus that patient-centeredness
involves the doctor being open and responsive
to the concerns and needs of patients (including
their need for information and participation in
decision-making), there is no one agreed deﬁni-
tion. Attempts have nevertheless been made to
‘operationalize’ patient-centered care as a set of
behaviors. For example, a six-component ‘patient-
centered clinical method’ has been proposed [109],
which comprises:
 Exploring the disease experience;
 Understanding the whole person;
 Finding common ground regarding manage-
ment;
 Incorporating health promotion and disease
prevention;
 Enhancing the doctor–patient relationship;
 Being realistic.
Patient participation
This is a broad and loosely deﬁned concept encom-
passing shared decision-making, patient educa-
tion (including initiatives to promote public
understanding such as the National Patient
Library [110] in the USA) and involvement of
patients or consumer advocates in the process of
policy and guideline development [111].
Patient empowerment
Through the emergence of the Internet, public
campaigns by patient groups, and publicity sur-
rounding medical disasters, patients have trans-
formed from passive participants in the health-
care system to active players who are aware that
their personal wellbeing is at stake. Nowadays,
instead of blindly following the paternalistic
health-care system in which the doctor was
regarded as always knowing what was best,
patients expect to be well-informed and involved
in decisions relating to their own health. Thus,
empowerment has been broadly deﬁned as ‘. . . a
social process of recognizing, promoting and
enhancing people’s abilities to meet their own
needs, solve their own problems and mobilize
the necessary resources in order to control their
lives’ [112].
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The process of patient empowerment entails
helping the person to develop a sense of control
by educating them appropriately and encourag-
ing them to participate actively in medical encoun-
ters [113]. The concept is closely linked with
consumerism: ‘Consumerist behavior is only likely
to occur when the patient feels empowered to
question the doctor, make independent judge-
ments, or seek out alternative sources of informa-
tion’ [114].
Informed choice
This approach focuses on ensuring that patients
have all the facts they need to come to a decision
(i.e. available treatment options and their asso-
ciated risks and beneﬁts). In other words, it
emphasizes communication of information from
the professional to the patient. Once this has been
achieved, the patient must make the choice or
decision themselves, either alone or aided by rela-
tives or friends if desired. In the ‘pure’ version of
the informed choice model the doctor stands back
from the decision so as not to lead the patient.
However, in practice the doctor may offer or be
asked to offer an opinion in addition to stating the
evidence [115].
Not surprisingly, much of the work on inform-
ed choice has been conducted from the point of
view of avoiding future litigation when health-
care choices (e.g. about surgery) have to be
made.
Enablement
The term ‘enablement’ has often been used inter-
changeably with empowerment, although in
recent years it has come to describe a measurable
outcome of patient-focused consultations, rather
than a process per se, incorporating satisfaction
with the consultation and improved knowledge
and self-efﬁcacy. The outcome should be that the
patient feels empowered and that he or she has
been helped [116].
Shared decision-making
Shared decision-making describes a process
whereby the patient is actively encouraged to
participate in decision-making about their health
care. Reaching a shared decision involves several
stages:
 Information exchange between doctor and patient.
This information could include evidence or opi-
nion about lifestyle preferences/anxieties/per-
sonal circumstances.
 Deliberation of alternative treatment options. The
patient and doctor state their preferences. Con-
sensusmaybe reachedquickly or via aprocess of
persuasion and negotiation. Doctor and patient
may agree to disagree.
 Deciding what treatment to implement. The patient
and professional work together to build consen-
sus on the preferred treatment option. If con-
sensus cannot be reached the deliberation phase
may still be regarded as a shared event (as views
were shared) but the outcomeof thedeliberation,
i.e. the decision, is not.
Qualitative research has identiﬁed a number of
additional substages or ‘competencies’ involved in
shared decision-making (Table 4) [117].
Concordance
In 1995, a Royal Pharmaceutical Society working
group was formed to explore what was known
about the difﬁculties patients have in taking med-
ication as prescribed. This heralded a change in
Table 4 Competencies required by professionals for informed shared decision-making [117]
1. Develop a partnership with the patient
2. Establish or review the patient’s preferences for information (e.g. amount and format)
3. Establish or review the patient’s preferences for a role in decision-making (such as risk taking and degree of
involvement of self and others) and the existence and nature of any uncertainty about the course of action to take
4. Ascertain and respond to patient’s ideas, concerns, and expectations (e.g. about disease management options)
5. Identify choices (including ideas and information that the patient may have) and evaluate the research evidence in
relation to the individual patient
6. Present (or direct patients to) evidence, taking into account competencies 2 and 3, framing effects (i.e. how
presentation of the information may influence decision-making), etc. Help patient to reflect on and assess the impact of
alternative decisions with regard to his or her values and lifestyle
7. Make or negotiate a decision in partnership with the patient and resolve conflict
8. Agree an action plan and complete arrangements for follow up
 2002 Copyright by the European Society of Clinical Microbiology and Infectious Diseases, CMI, 8 (Suppl. 2), 43–68
56 Clinical Microbiology and Infection, Volume 8 Supplement 2, 2002
emphasis from simple compliance to what became
known as ‘concordance’ [118]. The philosophy
underlying concordance recognizes that the
reasons why patients do not comply with medica-
tion can be complex and can vary from person to
person. These reasons include poor understand-
ing of the condition or treatment; maladaptive
attitudes towards the medication or illness; prac-
tical barriers to medication use; and rational
choices based on personal utilities. The process
of achieving concordance involves two-way com-
munication whereby the patient and doctor share
information about the illness, its treatment and
the patient’s barriers to compliance, to give a
common understanding of the problem and its
origins. Solutions should be negotiated in the
light of this new understanding and the decision
about how to proceed should be shared by both
parties. Embedded in this approach is the idea
that the patient’s right to choose must be res-
pected even if their ultimate decision is medi-
cally ‘wrong’, provided that their choice is
appropriately informed. The concept of concor-
dance overlaps closely with the other models of
shared decision-making. The focus of concordance
research has been long-term medication for chro-
nic illnesses.
Implementing shared decision-making
Patient interventions
Patient–doctor interaction. Shared decision-making
can be implemented at the individual patient–
doctor level via several interventions. Firstly, it
is important for the physician to ascertain the
patient’s reasons for and expectations from the
consultation.
Secondly, there should be a negotiated treat-
ment approach, involving careful explanation
and reassurance if antibiotics are not used. This
can be reinforced by giving the patient a prescrip-
tion with a negotiated agreement to ‘save’ it for a
few days to see if the symptoms resolve by them-
selves. The delayed prescription approach has
been evaluated in three randomized trials. The
majority of patients did not pick up their antibio-
tics (i.e. 55% of patients with cough [119], 69%with
sore throat [23], and 76% with otitis media [24]).
Furthermore, patients who had been persuaded
not to redeem their prescription for an antibiotic
were less likely to consult or expect antibiotics in
the future for similar symptoms. These ﬁndings
are consistent with those from an observational
study of parents who did not receive expected
antibiotics. In this study, parents whowere offered
a contingency plan from the physician (i.e. the
possibility of receiving antibiotics in the future if
their child did not get better) had a higher mean
satisfaction score than those who did not (76 vs.
58.9; P< 0.05) [16]. Similarly, in another observa-
tional study 50% of patients did not redeem their
‘back-up’ prescriptions and 96% reported satisfac-
tion with their care [120].
Finally, there should be provision of advice
regarding the duration of symptoms and sympto-
matic relief. This may be in the form of a ‘pre-
scription’ to give an ‘outcome’ to the consultation.
Also, questionnaires completed in the waiting
room and information sheets have been used. A
randomized trial showed that provision of infor-
mation leaﬂets signiﬁcantly reduced the number
of repeat consultations for patients with symptoms
of lower RTI, regardless of whether or not they had
received antibiotics [27].
Together, these data suggest that patient
empowerment is likely to be a successful strategy
for reducing antibiotic prescribing and infection
control in primary care, just as it is in secondary
care [121].
Having considered several of the most common
approaches to patient involvement, we now turn
to practical advice regarding the question of how
best to modify patient demand for antibiotics.
Unlike other examples of health behavior change,
where the emphasis is largely on motivating peo-
ple to avoid risky behaviors (e.g. smoking) or
engage in healthy behaviors (e.g. taking exercise),
the primary behavioral change sought in the case
of antibiotic prescribing is reduced patient
demand. This behavioral change requires modiﬁ-
cation of patient expectations.
As already noted, the informed choice model of
patient involvement emphasizes the importance of
provision of information, which is intended to
enable patients to make rational choices. In the
case of antibiotics for minor conditions such as
sore throat, such information might commonly
involve evidence about the probability of the
symptoms having a viral rather than a bacterial
cause, the likely time course of symptoms, and the
likely ineffectiveness of antibiotics in changing
that time course. In some cases it may include
somediscussionofpopulationresistance.However,
qualitative research indicates that patients may
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not understand such information or may harbor
the belief that it does not apply to them, and hence
may either persist in demanding antibiotics or
come away from the consultation feeling dis-
gruntled if they are not prescribed [7]. With regard
to the information itself, the concept of population
resistance may be too abstract for the patient (or
even the doctor) to grasp and a more effective
method of persuasion may be to emphasize risks
to the individual patient, such as side-effects and
the possibility of ‘their’ bacteria becoming resis-
tant.
It is also important to consider doctors’ concerns
that not meeting patients’ expectations may jeo-
pardize their future therapeutic relationship [7].
Such concerns may explain doctors’ common fail-
ure to broach the subject of alternative strategies
and instead simply to administer antibiotics in the
belief that this will satisfy the patient. Patients,
on the other hand, indicated that they would
appreciate more information on these matters
[7]. This ﬁnding is supported by several studies
that have found that patient satisfaction is primar-
ily inﬂuenced by information and reassurance
rather than by antibiotic prescribing [7,9,10,17,
122,123]. In focus groups, parents also indicated
that they would be satisﬁed with the consultation
even if antibiotics were not prescribed, provided
the physician explained the reasons for the deci-
sion [124].
In view of the importance of elucidating and
tackling underlying concerns and expectations as
an aid to decision-making for both the patient and
professional, it is likely that the shared decision-
making approach will be more useful in the case of
antibiotic prescribing than the informed choice
approach [125]. The shared decision-making app-
roach involves a number of stages in which the
doctor and patient exchange information pertinent
to their perspectives, discuss the advantages and
disadvantages of alternative treatment strategies,
and come to an agreement about the way forward.
The process of shared decision-making can be
illustrated by showing how it would be applied to
speciﬁc cases [125]. For example: a patient presents
with a sore throat and requests antibiotics. The
doctor ﬁrst takes a history and examines the
patient and concludes that the source of infection
is most likely viral. The following stages then
occur:
 Information exchange. The doctor should com-
municate information about the patient’s
symptoms, his/her opinion about the cause,
the availability of alternative treatment options,
and evidence about their likely effectiveness
(including areas of uncertainty). The doctor
should elicit the patient’s feelings about their
symptoms, barriers such as past experiences
of apparently successful antibiotic therapies,
their level of understanding about the condition
and its treatment, and their preference for an
active or passive role in the decision-making
process. Alternative treatment options include
immediate antibiotic prescription, prescription
of anti-inﬂammatory or pain-relieving drugs,
advice to seek ‘over the counter’ sore throat
remedies, and delayed antibiotic prescription.
Delayed antibiotic prescription can be achieved
by asking the patient to wait 3 days and then, if
the throat is still sore, either return to the ofﬁce or
telephone for a prescription, or by providing a
prescription at the ﬁrst consultation which the
patient agrees to have dispensed only if symp-
toms persist.
 Deliberation of alternative treatment options. The
doctor should state his/her preferred treatment
strategy,making sure the patient has understood
the reasoning for this choice. The patient should
state his or her preference, bearing in mind the
doctor’s advice, the alternatives that have been
presented, and their own concerns.
 Deciding what treatment to implement. The doctor
and patient should attempt to reach agreement
on a way forward. If consensus is not possible,
the patient may choose to accept the doctor’s
preference or insist that his or her own prefer-
ence be met. In the latter case the individual
clinician must decide what is acceptable,
although a wholly patient-centered approach
would respect the patient’s right to choose.
Of course, such an approach must be tailored to
the individual patient. For example, patients may
vary in the extent to which they prefer to be
involved in treatment decisions. Some patients
indicate that they do not state their expectations
regarding a consultation because they believe that
it should be the doctor’s responsibility to assess the
situation and decide what should happen [7].
Clearly, it is important to elicit these views early
on. Likewise symptom severity and relative risk
averseness for different patients will inﬂuence a
doctor’s appraisal of alternative management
options. For example, patients with severe sore
throat may be less likely to accept a wait and see
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approach,whilstpatientswhoareaverse toriskmay
prefer to receive a prescription for anti-inﬂamma-
tories or painkillers as a means of obtaining rapid
relief whilst avoiding the risk of side-effects from
antibiotics. Although the process of achieving
shared, informed decisions may require additional
time in the ﬁrst instance, it may be reasoned that
well-informed patients will be less likely to present
with inappropriate demands for antibiotics in the
future, reducing long-term health-care costs. Such
strategies should ideally be combinedwith effective
mass media campaigns to promote better under-
standing of the issues associated with antibiotic
prescribing for sore throat.
Public information campaigns. The mass media fre-
quently cover health-related topics, are the leading
source of information about important health
issues, and are targeted by those who aim to
inﬂuence the behavior of health professionals
and patients. A Cochrane Systematic Review has
identiﬁed 17 studies (randomized trials, controlled
clinical trials, controlled before and after studies,
or interrupted time-series analyses) that have eval-
uated the effectiveness of mass media interven-
tions on health-service utilization. The participants
were health-care professionals, patients, and the
general public. Fourteen studies evaluated the
impact of formal mass media campaigns, and
three looked at media coverage of health-related
issues. All but one of the studies concluded that
mass media was effective. The authors concluded
that those engaged in promoting better uptake of
research information in clinical practice should
consider mass media as one of the tools that
may encourage the use of effective services and
discourage the use of those with unproven effec-
tiveness [126].
In Belgium, a public information campaign on
antibiotic resistance was associated with an 18%
reduction in antibiotic consumption the month
after the campaign period. This was statistically
signiﬁcant after adjustment for seasonal changes
in acute respiratory infection [127]. It is imperative
that patient organizations are actively involved in
the development of such education campaigns in
order to ensure that the perspective of the patient
has been taken into account.
Doctor interventions
AGREE is a project funded by the European Union
that aims to standardize the development of
evidence-based guidelines. Their recommenda-
tions (http://www.agreecollaboration.org) and
those of other groups such as the Scottish Inter-
collegiate Guidelines Network (SIGN) [111] recog-
nize the importance of including patients’ views in
the development of practice guidelines.
The importance of including patients’ views is
illustrated by a study of the implementation of a
guideline that aimed to reduce hospital admission
for patients with community-acquired pneumonia
who were at low risk of developing complications
[88]. The guideline was developedwith physicians
working in an accident and emergency depart-
ment. After implementation of the guideline phy-
sicians were still admitting 44% of patients whom,
by their own agreed criteria, had mild pneumonia
that did not require hospitalization. The explana-
tions given for nonadherence with the guidelines
were largely due to patient-related factors. For
example, physicians stated that the guideline
did not accurately assess the risk of individual
patients, patients or their carers were not happy
for the patient to be discharged, or that the
patient’s home circumstances were not suitable
for outpatient care [88].
There is now a large literature on methods for
changing the behavior of doctors and other health-
care professionals. The Cochrane Library includes
seven systematic reviews demonstrating the effec-
tiveness of a variety of educational methods in
practice [126,128–133]. However, to summarize
the current state of knowledge: there are ‘no magic
bullets’ [134]. All of the methods have been shown
to work in some circumstances but not in others.
The problem is that there is still no generic method
for predicting which interventions will work with
speciﬁc people and settings.
The Cochrane collaboration is currently sup-
porting two reviews of interventions to improve
antibiotic prescribing, one in ambulatory care and
one in hospital inpatients. The protocols for both
reviews are available on the Cochrane website
(http://www.update-software.com/cochrane).
Two studies suggest that interventions targeted at
education of both public and health-care profes-
sionals are more likely to succeed than educational
interventions targeted at either group alone. In
Cuba, combined intervention decreased antibiotic
prescribing by 63%, compared with a 23% de-
crease for professional education alone, and a
2% increase for public education alone. There
was a 48% increase in the control practices who
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received no intervention [135]. In the USA, a prac-
tice-based educational intervention alone using
patient information leaﬂets was ineffective: pre-
scribing declined from 78% to 76% compared with
a change from 82% to 77% in control practices.
However, the addition of a household-based edu-
cational intervention resulted in a signiﬁcant
decline in antibiotic prescription rates (from 74%
to 48%; P¼ 0.003) [136].
System interventions
Shifting the costs of prescribing from the insurer to
physicians in a staff model of a healthmaintenance
organization (HMO) did not appear to inﬂuence
antibiotic prescribing in a study of patients in
whom upper RTIs (n¼ 334) or acute bronchitis
(n¼ 218) were diagnosed within a 12-month per-
iod. For upper RTIs, antibiotic prescribing was
signiﬁcantly higher in the HMO population than
in the fee for service group (31% vs. 20%; P¼ 0.02).
In patients with acute bronchitis, HMO patients
were also more likely to have an antibiotic pre-
scribed, but the difference was not statistically
signiﬁcant (82% vs. 73%; P¼ 0.11). Further ana-
lyses showed that, while HMO physicians were
more likely to prescribe antibiotics, they were less
likely to prescribe other medications for acute
bronchitis or to use diagnostic tests for evaluation
of patients with upper RTIs or bronchitis [137].
In Denmark, reductions in the reimbursement of
antibiotics prescribed for certain infections was
associated with amarked reduction in prescribing.
In a prospective study, the prescribing behavior of
553 primary-care doctors in 1990 (after reimburse-
ment was reduced) was compared with that in
1987 (before reimbursementwas reduced). In 1987,
7607 patients were treated compared with 5765 in
1990. The relative number of patients treated for
sinusitis, other upper RTIs, acute bronchitis, pneu-
monia, and upper gynecological infections was
signiﬁcantly lower in 1990 than in 1987. Other
infections, particularly those that are often diag-
nosed by culture or microscopy by the doctors
themselves, increased signiﬁcantly. They included
tonsillitis and urinary tract infections. The authors
concluded that reimbursement can be a very
powerful tool controlling the use of antibiotics
by general practitioners [138].
Evaluation of interventions
The Cochrane Effective Practice and Organization
of Care group (EPOC) website provides access to a
series of methodology papers and a checklist for
assessment of reports of interventions designed to
change clinical practice (http://www.abdn.ac.uk/
hsru/epoc/). In addition to controlled trials,
Cochrane EPOC reviews include quasi-experi-
mental study designs, such as controlled before
and after studies and interrupted time-series ana-
lyses [139]. Uncontrolled before and after studies
almost always overestimate the impact of inter-
ventions [140] and give no indication of changes
that would have occurred without the interven-
tion. Controlled before and after studies compare
the impact of an intervention in, for example, a
hospital or primary-care group with a comparable
site. The EPOC methodology papers provide
advice on ensuring comparability of intervention
and control sites and on statistical methods for
comparing changes in both sites. An interrupted
time-series analysis uses the intervention site as its
own internal control by comparing several mea-
surements before and after the intervention. The
most common errors in interrupted time series are
to have too few data points before the intervention
and to base statistical analysis on a comparison of
averagemeasures before and after the intervention
rather than on an analysis of time trends. At least
three measurements are required before and after
the intervention to analyze trends. However, the
larger the number of data points before the inter-
vention, the more reliable the results.
OPPORTUNITIES FOR
IMPROVEMENT AND IMMEDIATE
ACTION
Strategies for involving patients in developing
countries must recognize the fundamental need
for improvement in access to medical services,
including antibiotic treatment. In other words, in
developing countries the ﬁrst barrier to overcome
is becoming a patient in the ﬁrst place.
General health literacy is improving through the
inﬂuence of new media, including the Internet.
There are already some excellent websites that
provide information for consumers, both about
antibiotics and about the importance of the normal
ﬂora to human health. For example:
 Alliance for the Prudent Use of Antibiotics (APUA)
(http://www.healthsci.tufts.edu/apua/Patients/
patient.html). This association has an excellent
website with a consumer page and good links
to other sources of information. Health-care
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consumers can learn how they can help to
improve the use of antibiotics by understanding
the drugs and by following their doctors’ advice
about taking them.
 Do Bugs Need Drugs? (http://www.dobugs-
needdrugs.org). This is a Canadian website
designed to inform consumers and the public
about antibiotics and their effects. This website
provides information for health-care profes-
sionals, the public, teachers, parents’ and chil-
dren. Guidelines for managing RTIs, including
colds, ﬂu, sore throat, cough, earaches, sinus
infections, chest colds (bronchitis) and pneumo-
nia, can be found in the Parent and the Health-
care Professional Sections.
 NIPA: Canada’s National Information Program
onAntibiotics (http://www.antibiotics-info.org/
anti01.html). NIPA is a group of health-care
organizations dedicated to promoting the appro-
priate use of antibiotics. This website contains
information for consumers and health-care
professionals on a variety of topics surround-
ing the rising issue of antibiotic resistance in
Canada.
A patient-centered approach to the manage-
ment of RTIs, as well as other conditions, may
require longer consultations between patients and
doctors. This may necessitate changes in health-
care systems that are beyond the scope of this
paper. Increased consultation time needs to be
accompanied by changes in attitudes (away from
the paternalistic toward a more patient-centered
approach), improved health literacy and consult-
ing behavior among patients, and improved com-
munication skills among physicians. However,
these changes are all achievable.
Education of patients and doctors is not only
concerned with providing facts; it is also con-
cerned with changing beliefs and attitudes. In
relation to antibiotics this means increasing aware-
ness of the risks of antibiotic treatment to the
individual. There is currently an excessive empha-
sis on a binary approach to bacterial infection:
patients either have bacterial infection or they
do not. Doctors are angered by advice such as
‘don’t prescribe antibiotics for viral sore throats’.
If they knew for certain that the patient had a viral
infection, they would not prescribe an antibiotic.
The problem is that they are faced with patients
who might have bacterial infection and their cur-
rent belief is ‘if in doubt, treat’. Patient leaﬂets
carry messages such as ‘unnecessary antibiotics
may be harmful’. The decision to prescribe anti-
biotics is therefore a balance between expected
risks and beneﬁts. The distinction between neces-
sary and unnecessary prescribing is only impor-
tant for the beneﬁt side of this equation. The reality
of the risk side of the equation is that every course
of antibiotics we take damages the normal ﬂora,
whether the treatment was necessary or unneces-
sary. Doctors need to feel conﬁdent that not pre-
scribing antibiotics is sometimes in the best
interests of the patient. For example, patients need
to understand that if they have acute bronchitis
they will be ill for about 2weeks whether or not
they take antibiotics and that, at best, antibiotics
may shorten the illness by a day.
Patients present with symptoms, not infections,
and doctors have to help them to understand the
probability a of bacterial infection. They can then
assess the relative beneﬁcial vs. harmful effects of
antibiotics. In this complex situation, decision-
support tools can be used to help the doctor and
the patient before, during, and after the consulta-
tion (Figure 1). Information provided before the
consultation may be critical to change the knowl-
edge, attitudes, and beliefs of patients or doctors to
a point where they are ready to employ shared
decision-making during or after the consultation.
Key players include patient networks/organiza-
tions, pharmacists, employers, schools, nurseries/
child carers, the pharmaceutical industry, govern-
ments, and the media. A recent Cochrane review
has conﬁrmed the effectiveness of mass media
campaigns for inﬂuencing the way that the public
makes decisions about their use of health care
[126].
IMPORTANT AREAS OF
UNCERTAINTY
Is shared decision-making feasible in routine
clinical practice?
To be successful this requires signiﬁcant changes
in attitudes (away from paternalistic, toward a
more patient-centered approach), improved com-
munication skills among physicians, and
improved health literacy and consulting behavior
among patients. Changes in attitudes need to be
supported by changes in health-care systems,
including either increased consultation time or
changes in the way that consultations occur with
much more preparation of the patient and the
doctor before the consultation.
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Will the shared decision-making and patient-
centered approaches developed in chronic
illnesses work in acute infections?
The principles are the same, as far as sharing
decisions is concerned, but the emphasis may be
different, depending on the condition and the type
of behavior you want to change. For example, in
many chronic diseases the emphasis is on encoura-
ging preventive behaviors (antismoking or safe
sex) or on compliance with effective, long-term
treatment. It remains to be determined whether
strategies that work in these contexts will be
equally effective for changing the expectations of
people with sore throats.
How important are cultural differences
between and within countries?
A key limitation of existing research is that it is
dominated by studies from the USA or Western
Europe (Tables 1,2,3). We have very limited infor-
mation on the importance of cultural variation
between countries/regions (and even within mul-
ticultural societies) to the appropriateness and
application of patient-centered health care and
shared decision-making. However, the limited
available evidence suggests that cultural varia-
tions are very important. At the same time,
although cultural variations clearly exist in dis-
cussing priorities for health care, there seems to be
a universal agreement on the importance of certain
aspects of health-care decision-making, such as the
doctor–patient relationship, information and sup-
port, and availability of and access to treatment
[141].
Which patients want to engage in shared
decision-making?
Evenwithin a uniform cultural group, therewill be
varying enthusiasm for shared decision-making.
Figure 1 Intervention: when and how to communicate. We know that almost any intervention works some of the time and
fails to work part of the time—but why? The above model tries to illustrate the different points of intervention, the vehicles
for intervention, and the pros and cons of directing action at this stage.
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Not all patients want to be empowered at all times;
some might prefer to leave decisions about their
health care to an expert whom they trust. Age,
ethnicity, gender and social class may all inﬂuence
habits, preferences and expectations.
CONCLUSIONS
Being the ultimate consumers of antibiotics,
patients are fundamental to any efforts to control
antibiotic usage and resistance. Informed public
representation must be encouraged.
The debate on antibiotic prescribing and resis-
tance needs to move beyond the traditional
assumptions about patients’ demand for anti-
biotics. Patients may lack knowledge about cor-
rect antibiotic use and may be subject to cultural
bias against ‘germs’ combined with little knowl-
edge of the risk that resistance may have for
their health. However, the evidence suggests that
there has been gross overestimation of the im-
portance of patient demands as drivers of anti-
biotic prescribing and resistance. The explanation
lies in physicians’ misperceptions of patients’
more fundamental needs and health-care expecta-
tions.
We have identiﬁed evidence that supports
initiatives to encourage shared decision-making
as a driver for behavioral change. However, these
initiatives would need to be underpinned by edu-
cational initiatives in order to achieve broader
changes in attitudes. Patient organizations offer
a unique means of access to the patient’s perspec-
tive. Public information campaigns do work but
the effect of any individual campaign is transient
so these interventions must be sustained.
Research should focus on extending the
encouraging results regarding the effectiveness
of shared decision-making in upper RTIs. As all
of the research so far is from Western Europe and
North America, we need evidence that the same
success can be achieved in other cultural settings.
At the same time we need evidence about the role
of shared decision-making in other disease areas,
especially those where problems are less easy to
deal with without medical help (e.g. cystitis).
Finally, we need research on methods for educat-
ing the public about antibiotic resistance and the
role of bacteria in human health. At present, few
patients really understand these issues and pre-
scribers are only a little better informed.
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